Category

Archives

Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication

Endosomal sorting complex required for transport (ESCRT) is essential in the functional operation of endosomal transport in envelopment and budding of enveloped RNA viruses. However, in nonenveloped RNA viruses such as enteroviruses of the Picornaviridae family, the precise function of ESCRT pathway in viral replication remains elusive. Here, we initially evaluated that the ESCRT pathway is important for viral replication upon enterovirus 71 (EV71) infection. Furthermore, we discovered that YM201636, a specific inhibitor of phosphoinositide kinase, FYVE finger containing (PIKFYVE) kinase, significantly suppressed EV71 replication and virus-induced inflammation in vitro and in vivo. Mechanistically, YM201636 inhibits PIKFYVE kinase to block the ESCRT pathway and endosomal transport, leading to the disruption of viral entry and replication complex in subcellular components and ultimately repression of intracellular RNA virus replication and virus-induced inflammatory responses. Further studies found that YM201636 broadly represses the replication of other RNA viruses, including coxsackievirus B3 (CVB3), poliovirus 1 (PV1), echovirus 11 (E11), Zika virus (ZIKV), and vesicular stomatitis virus (VSV), rather than DNA viruses, including adenovirus 3 (ADV3) and hepatitis B virus (HBV). Our findings shed light on the mechanism underlying PIKFYVE-modulated ESCRT pathway involved in RNA virus replication, and also provide a prospective antiviral therapy during RNA viruses infections.

 

Comments:

The passage you provided discusses the role of the endosomal sorting complex required for transport (ESCRT) pathway in viral replication, specifically focusing on its involvement in enveloped RNA viruses and nonenveloped RNA viruses like enteroviruses of the Picornaviridae family. The passage describes the discovery that a specific inhibitor called YM201636, which targets a kinase called phosphoinositide kinase, FYVE finger containing (PIKFYVE), effectively suppresses the replication of enterovirus 71 (EV71) and other RNA viruses.

The researchers found that YM201636 inhibits PIKFYVE kinase, which in turn blocks the ESCRT pathway and endosomal transport. This disruption of the ESCRT pathway and endosomal transport impairs viral entry and replication complex formation within subcellular components. Consequently, intracellular replication of RNA viruses, including EV71, coxsackievirus B3 (CVB3), poliovirus 1 (PV1), echovirus 11 (E11), Zika virus (ZIKV), and vesicular stomatitis virus (VSV), is repressed. Notably, YM201636 did not show broad antiviral activity against DNA viruses like adenovirus 3 (ADV3) and hepatitis B virus (HBV).

The study's findings provide insights into the mechanism by which PIKFYVE kinase modulates the ESCRT pathway during RNA virus replication. Furthermore, the researchers suggest that YM201636 or similar inhibitors could be explored as potential antiviral therapies for RNA virus infections.

Related Products

Cat.No. Product Name Information
S1219 YM201636 YM201636 is a selective PIKfyve inhibitor with IC50 of 33 nM, less potent to p110α and insensitive to Fabl (yeast orthologue). YM-201636 suppresses the growth of liver cancer via the induction of autophagy.

Related Targets

PIKfyve Autophagy PI3K